Jefferies Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Jefferies Group’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-48,900	Closed	-$455K	–	2590
2015 Q4	$455K	Buy	48,900 +22,000	+82%	+$220K	﹤0.01%	1582
2015 Q3	$303K	Buy	26,900 +23,600	+715%	+$289K	﹤0.01%	1756
2015 Q2	$42K	Buy	+3,300	New	+$35.6K	﹤0.01%	2489
2015 Q1	–	Sell	-514,300	Closed	-$7.37M	–	2412
2014 Q4	$7.37M	Buy	+514,300	New	+$6.09M	0.04%	324
2014 Q3	–	Sell	-71,500	Closed	-$1.16M	–	2466
2014 Q2	$1.16M	Sell	71,500 -196,900	-73%	-$2.62M	0.01%	850
2014 Q1	$4.36M	Buy	268,400 +112,500	+72%	+$1.6M	0.04%	350
2013 Q4	$1.94M	Buy	+155,900	New	+$1.57M	0.01%	587

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jefferies Group's VNDA Position: Q1 2022 in Review

Jefferies Group sold out of Vanda Pharmaceuticals (VNDA) in Q1 2022, closing a stake of 3,914 shares — an estimated $61.4K sold.

Jefferies Group first reported a position in VNDA in Q3 2013 and held it in 13 quarters. The position peaked at $7.72M in Q1 2015. 188 funds tracked by Wall St. Rank hold VNDA as of Q1 2022.

Jefferies Group reported no remaining Vanda Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Jefferies Group sold 3,914 Vanda Pharmaceuticals shares in Q1 2022, an estimated $61.4K.
Jefferies Group first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 13 quarters.
Jefferies Group's Vanda Pharmaceuticals position peaked at $7.72M in Q1 2015.
188 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.